Vicarious Surgical Dividends and Buybacks
Dividend criteria checks 0/6
Vicarious Surgical does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.05%
Buyback Yield
| Total Shareholder Yield | -0.05% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate
Nov 30
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Aug 16Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Mar 05Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Nov 24Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 18Vicarious Surgical: Cash Burn Adds To Downside Risk
May 26Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02
Feb 13Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03
Nov 07Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02
Aug 08Vectoring In On Vicarious Surgical Inc.
Jun 23Vicarious Surgical: Developing Minimally Invasive VR Surgical System
Nov 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if RBOT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RBOT's dividend payments have been increasing.
Dividend Yield vs Market
| Vicarious Surgical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RBOT) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Medical Equipment) | 1.8% |
| Analyst forecast (RBOT) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate RBOT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RBOT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate RBOT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as RBOT has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/12 23:05 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vicarious Surgical Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Gorman | BTIG |
| Matthew Miksic | Credit Suisse |
| Adam Maeder | Piper Sandler Companies |